32.jpg)
56.jpg)
USE OF BCL7A FOR THE DIAGNOSIS, PROGNOSIS, PREVENTION, IMPROVEMENT, RELIEF OR TREATMENT OF DIFFUSE LARGE B-CELL LYMPHOMA, AND METHODS, KITS AND DEVICES BASED ON SAID USE
Patent number:
WO21260250
No items found.
Use of BCL7A for the diagnosis, prognosis, prevention, improvement, relief or treatment of diffuse large B-cell lymphoma, and methods, kits and devices based on said use. The present invention describes BCL7A for use in the diagnosis, prognosis, prevention, improvement, relief or treatment of diffuse large B-cell lymphoma, and methods, kits and devices based on said use.
Countries:
Spain
Regions:
Andalusia
Centers:
UNIVERSIDAD DE GRANADA, SERVICIO ANDALUZ DE SALUD
Other entities:
Sectors:
Health
Subsectors:
Biotechnology
TRL Level:
TRL 2 – technology concept formulated
BRL Level:
PDF Link:
Download hereVideo Link:
Watch it hereSustainable Development Goal:
Applications
- Less destruction of proximal healthy tissue. - Reduction of the possibility of resistance, recurrence and tumor metastasis. - Changes in the phenotype of CSCs and elimination of the CSC subpopulation of the tumor. - Useful for the treatment of tumors with greater depth.
Comments